Vertex Pharmaceuticals (VRTX) Stock Price
$485 1%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
8 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Vertex Pharmaceuticals, AI stock picks, stock alerts and much more.
VRTX AI Stock Analysis
Financial Performance
The financial performance of Vertex Pharmaceuticals has been strong and consistent, with revenue growth of 10.1% YoY and a gross profit increase of 10.7% YoY. The operating income profit witnessed a significant surge by 131.7% from the previous quarter and up by 16.4% YoY, indicating efficient operations management and cost control measures in place.
Stock Price
The stock price is currently trading at $453.2, marking an increase of 6.8% over the past month and an overall annual gain of 8.5%. However, the stock is slightly below its 200-day moving average ($461.68), suggesting cautious investor sentiment in the medium term despite recent gains.
Alternative Data Signals
Website traffic trends indicate a robust increase in interest towards the company with a monthly visitor count growing by 19.2%. Job postings have also seen decent growth (13.7%), implying potential expansion plans or increased workload within the company which could translate into future growth prospects for Vertex Pharmaceuticals.
A very positive business outlook reported by employees suggests high morale which could contribute to productivity improvements while increasing social media followers on Instagram indicates improved brand visibility.
Conclusion
In conclusion, considering stable financial performance, positive alternative data signals, but slightly cautious investor sentiment reflected in stock price trends; our AI analysis leans towards a moderately bullish view on Vertex Pharmaceuticals' stock.
Note: This AI Stock Analysis is based on data as of February 13. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Vertex Pharmaceuticals (VRTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vertex Pharmaceuticals (VRTX), currently trading at $485, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VRTX
-
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
-
Symbol
VRTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
124.5B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.55 2.3% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.23 0.5% |
2 |
 |
Moderna MRNA |
$35.54 5.4% |
4 |
 |
Anavex Life Sciences AVXL |
$8.58 1.2% |
6 |
 |
BridgeBio Pharma BBIO |
$36.68 0.3% |
5 |
News
VRTX Alternative Data
Web Traffic
Vertex Pharmaceuticals receives an estimated 406122 monthly visitors to vrtx.com.
-
Web Traffic
406122
-
Change from Previous Month
19.2%
-
3 Month Change
17.3%
-
YoY Change
17.3%
News Mentions
Vertex Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Vertex Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
Twitter Followers
Vertex Pharmaceuticals has 71,208 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
71208
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Instagram Followers
Vertex Pharmaceuticals has 11,316 Instagram Followers on its main Instagram account, up by 0.9% over the last month.
-
Instagram Followers
11316
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
4.3%
-
YoY Change
4.3%
Youtube Subscribers
Vertex Pharmaceuticals has 2,430 subscribers on its main Youtube channel, up by 2.5% over the last month.
-
Youtube Subscribers
2430
-
Daily Change
0%
-
1 Month Change
2.5%
-
3 Month Change
6.1%
-
YoY Change
6.1%
LinkedIn Followers
423,520 are following Vertex Pharmaceuticals on LinkedIn, up by 3.1% over the last month.
-
LinkedIn Followers
423520
-
Daily Change
0.1%
-
1 Month Change
3.1%
-
3 Month Change
6.4%
Job Postings
Vertex Pharmaceuticals currenly has an estimated 217 open job postings, up by 4.8% over the last month.
-
Job Postings
217
-
Daily Change
1.4%
-
1 Month Change
4.8%
-
3 Month Change
1.9%
-
YoY Change
1.9%
LinkedIn Employees
According to LinkedIn, Vertex Pharmaceuticals has 5,799 employees, up by 1.1% over the last month.
-
LinkedIn Employees
5799
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
4.8%
-
YoY Change
4.8%
Business Outlook
-
Business Outlook
92
-
Change from Previous Month
1.1%
-
3 Month Change
0%
-
YoY Change
0%
VRTX Financials
VRTX Key Metrics
-
Total Revenue
$2.8B
-
Net Income
$1B
-
Earnings per Share
$4.05
-
Free cash flow
$1.5B
-
EBITDA
$1.1B
-
EBITDA Ratio
0.40272
-
Total Assets
$22.2B
VRTX 2-year Revenue & Income
VRTX 2-year Free Cash Flow
VRTX Technicals
VRTX SMA
VRTX RSI
FAQ
What's the current price of Vertex Pharmaceuticals (VRTX) Stock?
The price of an Vertex Pharmaceuticals (VRTX) share is $485.
What's the market cap of Vertex Pharmaceuticals?
The current market cap of Vertex Pharmaceuticals is 124.5B.
Should I buy or sell VRTX?
Multiple alternative data signals suggest that Vertex Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Vertex Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Vertex Pharmaceuticals stock. The bullish indicators suggest that Vertex Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Vertex Pharmaceuticals (VRTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Vertex Pharmaceuticals stock, given the bullish outlook.
What are some stocks similar to Vertex Pharmaceuticals (VRTX) that investors often compare it to?
Vertex Pharmaceuticals (VRTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Vertex Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vertex Pharmaceuticals' stock price to be around $531.3 in 2026. Starting from the current price of $485, this represents a 9.6% change in price, indicating a bullish outlook for the stock.
How to buy Vertex Pharmaceuticals (VRTX) Stock?
Vertex Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vertex Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.